Pharma BD Deal Intelligence
Stryker Corporation / Trauson Holdings Company Limited
2013 · Acquisition/Merger · $764M · Complete
Announcement Sentiment
86
Strongly positive
Stryker offered HK$7.50/share cash (total $764M, EV ~$685M) for Chinese orthopedics maker Trauson; expanded China/EM footprint in trauma and spine.
Did it work? Outcome assessment
Strategic verdict
Partially Achieved
Assessment window: 10yr post-close.
Key facts
- Announced Jan 17, 2013
- Closed Mar 01, 2013
- Deal value $764M
- Deal type Acquisition/Merger
- Therapeutic area Orthopedic trauma / spine
- Indications Orthopedic trauma / spine
- Key assets Trauma and spine implants (China)
- Mechanism Mixed orthopedic device portfolio
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals